Chimerix, Inc. (CMRX)
Apr 21, 2025 - CMRX was delisted (reason: acquired by JAZZ)
8.54
-0.01 (-0.12%)
Inactive · Last trade price on Apr 17, 2025
Chimerix Employees
Chimerix had 79 employees as of December 31, 2024. The number of employees increased by 7 or 9.72% compared to the previous year.
Employees
79
Change (1Y)
7
Growth (1Y)
9.72%
Revenue / Employee
$2,684
Profits / Employee
-$1,118,823
Market Cap
801.08M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 79 | 7 | 9.72% |
| Dec 31, 2023 | 72 | -17 | -19.10% |
| Dec 31, 2022 | 89 | 2 | 2.30% |
| Dec 31, 2021 | 87 | 33 | 61.11% |
| Dec 31, 2020 | 54 | 11 | 25.58% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
CMRX News
- 4 months ago - Top 3 Health Care Stocks That May Crash In Q2 - Benzinga
- 4 months ago - Biotech Stocks Q1 2025 Recap: Winners And Underperformers - Seeking Alpha
- 5 months ago - Chimerix Reports Fourth Quarter and Year End 2024 Financial Results - GlobeNewsWire
- 5 months ago - CHIMERIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chimerix, Inc. - CMRX - Business Wire
- 5 months ago - Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CMRX and GLYC on Behalf of Shareholders - PRNewsWire
- 5 months ago - Jazz Pharma To Buy Chimerix For $935 Million, Strengthening Rare Cancer Pipeline - Benzinga
- 5 months ago - Jazz Pharmaceuticals to buy Chimerix for $935 million - Reuters